Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia.
Reeves, William C, Jones, James F, Maloney, Elizabeth et al. · Population health metrics · 2007 · DOI
Quick Summary
This study surveyed over 5,600 people in Georgia to find out how many have ME/CFS. Researchers found that about 2.5% of adults aged 18-59 have the condition, which is higher than estimates from other parts of the United States. Interestingly, the disease affected men and women very differently depending on whether they lived in cities or rural areas.
Why It Matters
This is one of the few large population-based prevalence studies of ME/CFS in the United States, providing crucial epidemiologic data to help healthcare systems and policymakers understand the disease burden. The striking geographic and sex-based variations suggest that ME/CFS may be underdiagnosed in some populations or that disease expression differs by region—questions that could guide future research and clinical screening strategies.
Observed Findings
Estimated CFS prevalence of 2.54% in Georgia adults aged 18-59
No significant differences in overall CFS prevalence between metropolitan, urban, and rural populations
No significant differences in CFS prevalence between white and black residents across regions
Dramatic variation in female-to-male prevalence ratios by geography: 11.2:1 in metropolitan areas, 1.7:1 in urban areas, and 0.8:1 in rural areas
Georgia prevalence estimate 6-10 times higher than previous population-based estimates from other U.S. geographic areas
Inferred Conclusions
ME/CFS affects approximately 1 in 40 working-age adults in Georgia, suggesting substantial public health burden
Geographic location influences the sex distribution of ME/CFS cases, though the mechanism is unknown
Broader screening criteria or different case definition application may explain higher Georgia prevalence compared to other regions
Additional stratified analyses by geographic region and demographic factors are needed to understand prevalence variations
Remaining Questions
Why do female-to-male ratios differ so dramatically between metropolitan, urban, and rural areas, and what factors drive this variation?
What This Study Does Not Prove
This study does not establish causation for ME/CFS or identify what causes the disease. The cross-sectional design cannot prove why prevalence ratios differ so dramatically between geographic regions or whether differences reflect true disease prevalence, diagnostic bias, willingness to participate, or variation in case definition application. The higher overall prevalence compared to other regions may reflect methodological differences rather than true geographic variation.
Tags
Symptom:Fatigue
Method Flag:PEM Not DefinedWeak Case DefinitionSex-Stratified
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does Georgia actually have higher true ME/CFS prevalence than other U.S. regions, or do methodological differences (case definition, screening approach, participation rates) explain the higher estimates?
What clinical or demographic characteristics differ between ME/CFS cases in metropolitan versus rural areas?
Why were no racial differences detected, and were adequate numbers of diverse participants included to reliably test this?